 |
|
Study questions impact of hemoglobin variations on mortality in dialysis patients
December 06, 2007Risk of death linked to persistently low hemoglobin, not variability itself
For patients with dialysis-related anemia, the risk of death is increased when hemoglobin levels remain persistently low over a period several months-not necessarily when they fluctuate over time, according to a study in the January Clinical Journal of the American Society of Nephrology.
"Our results show that the effect of hemoglobin variability on mortality, beyond the absolute level of hemoglobin, may not confer much additional risk, after adjusting for other illnesses and hospitalizations," comments David T. Gilbertson, Ph.D., of the Minneapolis Medical Research Foundation, Minneapolis, Minn.
Dr. Gilbertson and colleagues used data on nearly 160,000 dialysis patients to analyze the effects of variations in hemoglobin level on the risk of death. Patterns of hemoglobin variability during the first six months of 2004 were analyzed and compared with mortality rates over the subsequent six months.
Hemoglobin is the oxygen-carrying compound in the blood. Anemia, or low hemoglobin levels, is one of the most frequent complications of kidney failure and is associated with an increased risk of death in dialysis patients. Treatment including erythropoietin and intravenous iron has been a major advance in the management of kidney failure-related anemia, yet low blood counts and variation in hemoglobin levels continue to be a problem for many dialysis patients.
In the study, patients who developed low hemoglobin levels during the monitoring period were at increased risk of death. This was true both for patients with temporary reductions in hemoglobin and those whose hemoglobin level was persistently low. This risk was considerably greater than any risk associated with fluctuations in hemoglobin levels.
On further analysis, the key risk factor seemed to be the amount of time spent with a low hemoglobin level-not the hemoglobin variations themselves. Patients who spent three months or longer with low hemoglobin levels had the highest mortality rates.
"A number of research groups have shown that variability of hemoglobin levels is very common in patients receiving dialysis for end-stage renal disease," says Dr. Gilbertson. "Low hemoglobin levels, which are an indication of anemia, have been shown to be associated with poor outcomes. It is relatively unknown whether fluctuations in hemoglobin levels add additional risk." If so, then more intensive treatment might be needed to keep hemoglobin levels within a relatively narrow range.
"Our results suggest that fluctuations in hemoglobin levels probably do not add much to the mortality risk for patients with dialysis-related anemia," Dr. Gilbertson concludes. "Low hemoglobin levels show significantly greater associations with increased risk of death than fluctuations in hemoglobin levels." More research will be needed to evaluate the causes of variations in hemoglobin levels, including what proportion of the variability is under the control of doctors and dialysis centers.
American Society of Nephrology
Dr. Gilbertson and colleagues used data on nearly 160,000 dialysis patients to analyze the effects of variations in hemoglobin level on the risk of death. Patterns of hemoglobin variability during the first six months of 2004 were analyzed and compared with mortality rates over the subsequent six months.
Hemoglobin is the oxygen-carrying compound in the blood. Anemia, or low hemoglobin levels, is one of the most frequent complications of kidney failure and is associated with an increased risk of death in dialysis patients. Treatment including erythropoietin and intravenous iron has been a major advance in the management of kidney failure-related anemia, yet low blood counts and variation in hemoglobin levels continue to be a problem for many dialysis patients.
In the study, patients who developed low hemoglobin levels during the monitoring period were at increased risk of death. This was true both for patients with temporary reductions in hemoglobin and those whose hemoglobin level was persistently low. This risk was considerably greater than any risk associated with fluctuations in hemoglobin levels.
On further analysis, the key risk factor seemed to be the amount of time spent with a low hemoglobin level-not the hemoglobin variations themselves. Patients who spent three months or longer with low hemoglobin levels had the highest mortality rates.
"A number of research groups have shown that variability of hemoglobin levels is very common in patients receiving dialysis for end-stage renal disease," says Dr. Gilbertson. "Low hemoglobin levels, which are an indication of anemia, have been shown to be associated with poor outcomes. It is relatively unknown whether fluctuations in hemoglobin levels add additional risk." If so, then more intensive treatment might be needed to keep hemoglobin levels within a relatively narrow range.
"Our results suggest that fluctuations in hemoglobin levels probably do not add much to the mortality risk for patients with dialysis-related anemia," Dr. Gilbertson concludes. "Low hemoglobin levels show significantly greater associations with increased risk of death than fluctuations in hemoglobin levels." More research will be needed to evaluate the causes of variations in hemoglobin levels, including what proportion of the variability is under the control of doctors and dialysis centers.
American Society of Nephrology
Hemoglobin Levels Current Events and Hemoglobin Levels News RSSDrugs to treat anemia in cancer patients linked to thromboembolism
Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center.
Ironing out the genetic cause of hemoglobin problems
A gene with a significant effect on regulating hemoglobin in the body has been identified as part of a genome-wide association study, which looked at the link between genes and hemoglobin level in 16,000 people.
The prevalence of gluten-sensitive enteropathy in iron-deficient anemia patients
Gluten sensitive enteropathy (GSE) is an autoimmune enteropathy due to food gluten intolerance in genetically predisposed people.
Studies examine quality of care for hospitalized sickle cell disease patients
A study assessing the quality of care for patients with sickle cell disease in a variety of hospital settings will be presented at a press conference on Saturday, December 6, at 9:30 a.m., during the 50th Annual Meeting of the American Society of Hematology in San Francisco, CA.
Gene therapy corrects sickle cell disease in laboratory study
Using a harmless virus to insert a corrective gene into mouse blood cells, scientists at St. Jude Children's Research Hospital have alleviated sickle cell disease pathology.
Preventing anemia is important to kidney disease patients' quality of life
Maintaining sufficient red blood cell levels is important to the physical and mental health of patients with chronic kidney disease (CKD), according to a study appearing in the January 2009 issue of the Clinical Journal of the American Society Nephrology (CJASN). The findings indicate that preventing anemia in kidney disease patients should be an integral part of their care.
Moran Eye Center researchers find gene linked to severe diabetic eye and kidney diseases
Researchers at the John A. Moran Eye Center at the University of Utah and collaborative institutions have identified a gene called erythropoietin (EPO) that contributes to increased risk of severe diabetic eye and kidney diseases, called retinopathy and nephropathy.
Iron supplements might harm infants who have enough
A new study suggests that extra iron for infants who don't need it might delay development -- results that fuel the debate over optimal iron supplement levels and could have huge implications for the baby formula and food industry.
Drug for anemic cancer patients raises risk of death
Millions of cancer patients take drugs to boost their red blood cells and health when they become anemic after chemotherapy.
Novel small molecule therapy shows benefit for anemic patients via hydration of red blood cells
Researchers are identifying innovative therapeutics for sickle cell anemia that focus on specific factors in the disease's progression, such as the important role of hydration of the red blood cells.
More Hemoglobin Levels Current Events and Hemoglobin Levels News Articles
|
Ferritin, Hemoglobin Linked to Alopecia.(lower iron and hemoglobin levels are risk factors for alopecia): An article from: Skin & Allergy News by Miriam E. Tucker (Author) This digital document is an article from Skin & Allergy News, published by International Medical News Group on July 1, 2001. The length of the article is 2205 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Ferritin, Hemoglobin Linked to Alopecia.(lower iron and hemoglobin levels are risk factors for alopecia) Author: Miriam E. Tucker Publication: Skin & Allergy News (Magazine/Journal) Date: July 1, 2001 Publisher: International Medical News Group Volume: 32 Issue: 7 Page: 28 Distributed by Thomson... | |
 |
Landmark Diagnostics Home Blood Test for A1C Diabetes Hemoglobin levels by Landmark Diagnostics Landmark/HealthPoint Diagnostics A1c Test measures a diabetes patients total glycated hemoglobin (hemoglobin A1c) & accurately measures the average blood glucose (blood sugar) level over the previous 60-90 days. |
 |
Balneol For Her 3-Ounce., 3-Ounce. Bottle by Balneol Balneol for Her is specifically formulated to cleanse and soothe itching and irritation of the external vaginal area. Balneol for Her contains the same gentle and effective ingredients as Balneol, along with the active ingredient Hydrocortisone, a corticosteroid which reduces the swelling, itching, burning and inflammation caused by yeast infections and other feminine conditions. |
 |
Optimizing Hemoglobin Levels And Beyond: Strength For Living And Meaningful Survival? (Oncology) by M. Dicato (Author) |
|
Stabilizing hemoglobin levels: what's new in IV iron and anemia management?(Sponsored Educational Supplement): An article from: Nephrology Nursing Journal by Steven Fishbane (Author), Kristin Larson (Author), Suzann VanBuskirk (Author) This digital document is an article from Nephrology Nursing Journal, published by Jannetti Publications, Inc. on September 1, 2008. The length of the article is 7310 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. From the author: One of the challenges encountered by the nephrology nursing community is how to appropriately stabilize hemoglobin (Hb) levels. Recently, this issue has taken center stage in the anemia management environment, stemming from reports that the majority of patients on hemodialysis are not routinely maintained in an lib target range of 11 to 12 g/dL and that lib variability is associated with adverse outcomes.... | |
|
Effect of higher hemoglobin levels on health-related quality of life parameters. (Educational supplement: case study of the anemic patient).: An article from: Nephrology Nursing Journal by Nancy Gregory (Author) This digital document is an article from Nephrology Nursing Journal, published by Jannetti Publications, Inc. on February 1, 2003. The length of the article is 3025 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. From the author: A large body of clinical data has consistently demonstrated that improvements in health-related quality of life (QOL) are associated with hemoglobin (Hb) and hematocrit (Hct) levels maintained in the range recommended by the National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI). Hb (Hct) levels between 11 and 12 g/dL (33% to 36 %) yield... | |
|
Uterus is common source of genital bleeding. (Hemoglobin Levels Dictate Course).(Brief Article): An article from: Pediatric News by Norra MacReady (Author) This digital document is an article from Pediatric News, published by International Medical News Group on July 1, 2002. The length of the article is 503 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Uterus is common source of genital bleeding. (Hemoglobin Levels Dictate Course).(Brief Article) Author: Norra MacReady Publication: Pediatric News (Magazine/Journal) Date: July 1, 2002 Publisher: International Medical News Group Volume: 36 Issue: 7 Page: 28(1) Article Type: Brief Article Distributed by Thomson... | |
|
RH Blood Groups and Diabetic Disorders: Is There an Effect on Glycosylated Hemoglobin Level?: An article from: Human Biology by F. Gloria-bottini (Author), E. Antonacci (Author), N. Bottini (Author), A. Ogana (Author), P. Borgiani (Author), G. De Santis (Author), N. Lucarini (Author) This digital document is an article from Human Biology, published by Wayne State University Press on April 1, 2000. The length of the article is 3057 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: RH Blood Groups and Diabetic Disorders: Is There an Effect on Glycosylated Hemoglobin Level? Author: F. Gloria-bottini Publication: Human Biology (Refereed) Date: April 1, 2000 Publisher: Wayne State University Press Volume: 72 Issue: 2 Page: 287 Distributed by Thomson... | |
|
Stanbio Hemoglobin Tri-Level Controls, 2 mL 3/Bx by Stanbio Laboratory Hemoglobin Tri-Level Controls, includes 3 controls 2 mL each. | |
|
Relationships between hemoglobin and hematocrit levels and hospitalization and survival rates in dialysis patients. (Educational Supplement).: An article from: Nephrology Nursing Journal by Mary Brattich (Author) This digital document is an article from Nephrology Nursing Journal, published by Jannetti Publications, Inc. on April 1, 2003. The length of the article is 3509 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. From the author: Preserving life and reducing or limiting morbidity are the primary goals of dialysis therapy and the focus of day-to-day nursing assessments and interventions. A series of clinical analyses have shown that partial correction of anemia (to maintain hemoglobin [Hb] in the range of 11 to 12 g/dL and hematocrit [Hct] levels in the range of 33% to 36%) is associated with a 10% to 74%... |
| © 2009 BrightSurf.com |